| ASSET | MONTH | % RETURN |
|---|---|---|
Eli Lilly and (LLY) | November 2025 | 21.3% |
Merck (MRK) | November 2025 | 10.83% |
AstraZeneca PLC ADR (AZN) | November 2025 | 8.55% |
Philip Morris International (PM) | November 2025 | 8.44% |
AbbVie (ABBV) | November 2025 | 7.49% |
Johnson & Johnson (JNJ) | November 2025 | 7.15% |
Cisco Systems (CSCO) | November 2025 | 5.07% |
Berkshire Hathaway (BRK.A) | November 2025 | 4.57% |
Berkshire Hathaway (BRK.B) | November 2025 | 4.54% |
Alphabet Inc Class A (GOOGL) | November 2025 | 3.77% |
Novartis AG ADR (NVS) | November 2025 | 3.44% |
Exxon Mobil (XOM) | November 2025 | 3.39% |
Coca-Cola (KO) | November 2025 | 3.36% |
Abbott Laboratories (ABT) | November 2025 | 1.97% |
Thermo Fisher Scientific (TMO) | November 2025 | 1.8% |
McDonald’s (MCD) | November 2025 | 1.7% |
Royal Bank of Canada (RY) | November 2025 | 1.48% |
T-Mobile US (TMUS) | November 2025 | 0.94% |
PepsiCo (PEP) | November 2025 | 0.86% |
Walmart (WMT) | November 2025 | -0.21% |
Goldman Sachs (GS) | November 2025 | -0.45% |
Apple (AAPL) | November 2025 | -0.59% |
Shell PLC ADR (SHEL) | November 2025 | -0.64% |
HSBC Holdings PLC ADR (HSBC) | November 2025 | -0.76% |
Novo Nordisk A-S (NVO) | November 2025 | -0.83% |
Mega-cap stocks are treated as having a market cap of $200B+.
